A Novel arsenic -containing anti-cancer drug for triple negative breast cancer (TNBC) Grant

A Novel arsenic -containing anti-cancer drug for triple negative breast cancer (TNBC) .

date/time interval

  • July 1, 2023 - June 30, 2024

awarded by

administered by

sponsor award ID

  • Agreement 8/30/2023

contributor